| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals Inc (IRWD) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. IRWD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $7.13M | - | |
| VP | 658.0K | $2.47M | - | |
| Other | 500.5K | $1.88M | - | |
| Other | 416.6K | $1.56M | - | |
| Other | 350.4K | $1.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2017 | Olanoff Lawrence S | Director | Sell | 3,200 | $17.78 | $56,896.00 | -8.3% | |
| May 15, 2017 | McCourt Thomas A66 | Chief Commercial Officer | Sale+OE | 30,000 | $18.20 | $546,000.00 | -100% | |
| Mar 14, 2017 | Currie Mark G53 | Chief Scientific Officer | Sale+OE | 60,000 | $17.06 | $1,023,600.00 | -7.2% | |
| Mar 3, 2017 | Olanoff Lawrence S | Director | Sell | 3,200 | $17.19 | $55,008.00 | -12.3% | |
| Feb 24, 2017 | Consylman Gina | Chief Accounting Officer | Sell | 2,962 | $16.53 | $48,961.86 | -9.9% | |
| Feb 22, 2017 | Currie Mark G53 | Chief Scientific Officer | Sell | 1,800 | $16.94 | $30,492.00 | -7.8% | |
| Feb 22, 2017 | Graney Thomas | Chief Financial Officer | Sell | 1,874 | $16.94 | $31,745.56 | -4.2% | |
| Feb 22, 2017 | McCourt Thomas A66 | Chief Commercial Officer | Sell | 1,520 | $16.94 | $25,748.80 | -5.1% | |
| Feb 22, 2017 | Gilbert Halley E | Chief Legal Officer | Sell | 5,039 | $16.94 | $85,360.66 | -3.9% | |
| Feb 22, 2017 | Consylman Gina | Chief Accounting Officer | Sell | 1,839 | $16.94 | $31,152.66 | -2.9% |